東土科技(300353.SZ):參股公司的TSN芯片已取得小批量訂單
格隆匯9月7日丨有投資者通過互動平台向東土科技(300353.SZ)提問:尊敬的董祕你好,公司的AI 邊緣超腦已經有成品了麼,有什麼應用場景麼?公司的的TSN芯片有訂單了麼?謝謝
東土科技(300353.SZ)9月7日回覆稱,您好,公司智能控制器提供邊緣側的數據採集、存儲、模型分析等大數據處理,以軟件定義控制代替傳統控制方式,實現工業視覺、AI圖像識別等人工智能技術在工業領域的行業應用,是新一代人工智能技術着力於工業領域的硬件載體,已在清潔能源、半導體裝備、機器人、5G+雲化PLC、數字建造等領域實現業務導入。參股公司的TSN芯片已取得小批量訂單,感謝您的關注。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.